← All indications
Laryngeal Neoplasms
Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.
Drugs by status
Phase 4 trials (1)
Phase 3 trials (18)
Phase 2 trials (25)
- fluorothymidine
- 2-fluoropropionyl-labeled pegylated dimeric rgd peptide
- avelumab
- bmx-001
- gemcitabine
- gossypol
- nivolumab
- autologous natural killer cells
- ipatasertib
- hyaluronic acid
- sacituzumab govitecan
- celecoxib
- capecitabine
- cabozantinib
- sodium thiosulfate
- erlotinib
- lovastatin
- fludeoxyglucose f-18
- cemiplimab
- a166
- toripalimab
- bintrafusp alfa
- debio 1143
- cdx-1140
- lsta1
Phase 1 trials (10)
Organizations
Organization Involved with Phase 3 Indications (12)
Organization Involved with Phase 2 Indications (44)
- Celgene
- AstraZeneca
- Merck
- National Institutes of Health (NIH)
- Azienda USL 4 Prato
- Nova Scotia Health Authority
- University of Pennsylvania
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Case Western Reserve University
- Cornell University
- Eastern Cooperative Oncology Group
- ECOG-ACRIN Cancer Research Group
- Temple University
- University of Washington
- Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
- Ohio State University
- Southwest Oncology Group
- Stanford University
- University of Iowa
- University of Michigan
- University of South Florida
- University of Toronto
- University of Virginia
- University of Zurich
- Tel Aviv University
- University of California, Los Angeles
- University of California, San Diego
- University of California, San Francisco
- University of Utah
- Icahn School of Medicine at Mount Sinai
- +14 more
Organization Involved with Phase 1 Indications (17)
- Pharmacyclics
- Cleveland BioLabs
- Agennix
- The EMMES Corporation
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- AIDS Malignancy Consortium
- Cancer and Leukemia Group B (CALGB)
- Cancer Research UK
- Duke University
- Hoosier Cancer Research Network
- Sanford Health
- Sanford Research
- University of Birmingham
- University of Colorado, Denver
- Vanderbilt University
- Netherlands Cancer Institute
- Washington University in St. Louis
Organization Involved with Other Experimental Indications (4)